Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Polly A. Murphy Insider Profile
4 Followers
Polly A. Murphy, Director at Atea Pharmaceuticals, holds 56.45K shares in Atea Pharmaceuticals (Ticker: AVIR), holds 5.00K shares in Celcuity (Ticker: CELC).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-1.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Polly A. Murphy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Polly A. Murphy
Polly A. Murphy's Trading History
Atea Pharmaceuticals
Jun 18, 2024
Director
Uninformative Buy
119.67K
$180.06K
Celcuity
Nov 23, 2022
Director
Informative Buy
48.35K
$62.30K
List of latest transactions for each holding click on a transaction to see Polly A. Murphy's performance on stock
You May Also Like
Polly A. Murphy insider profile FAQ
What is the percentage of profitable transactions made by Polly A. Murphy?
The percentage of profitable transactions made by Polly A. Murphy is 50%.
What is the average return per transaction made by Polly A. Murphy?
The average return per transaction made by Polly A. Murphy is -1.20%.
What stocks does Polly A. Murphy hold?
Polly A. Murphy holds: AVIR, CELC stocks.
What was Polly A. Murphy’s latest transaction?
Polly A. Murphy latest transaction was an Uninformative Buy of $119.67K.
What was Polly A. Murphy's most profitable transaction?
Polly A. Murphy’s most profitable transaction was an Informative Buy of CELC stock on November 23, 2022. The return on the trade was 44.00%.
What is Polly A. Murphy's role in Atea Pharmaceuticals?
Polly A. Murphy's role in Atea Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.